Ascendis fires back at USITC complaint with suit seeking noninfringement declaration
MLex Summary: Ascendis Pharma sued rival BioMarin Pharmaceutical in the US Northern District of California, seeking a declaration of noninfringement for BioMarin’s C-type natriuretic peptides patent. BioMarin filed a complaint with...To view the full article, register now.
Already a subscriber? Click here to view full article